Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Adaptive Biotechnologies Corp (NASDAQ: ADPT) was $6.46 for the day, down -0.62% from the previous closing price of $6.50. In other words, the price has decreased by -$0.62 from its previous closing price. On the day, 1.16 million shares were traded. ADPT stock price reached its highest trading level at $6.625 during the session, while it also had its lowest trading level at $6.11.
Ratios:
Our analysis of ADPT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.52. In the meantime, Its Debt-to-Equity ratio is 1.00 whereas as Long-Term Debt/Eq ratio is at 0.96.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 18 ’24 when PISKEL KYLE sold 248 shares for $4.98 per share. The transaction valued at 1,235 led to the insider holds 154,330 shares of the business.
Taylor Stacy L sold 26,922 shares of ADPT for $121,079 on Aug 22 ’24. The SVP and General Counsel now owns 139,365 shares after completing the transaction at $4.50 per share. On Aug 22 ’24, another insider, STACY L TAYLOR, who serves as the Officer of the company, bought 26,922 shares for $4.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 959264704 and an Enterprise Value of 934360448. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.38 while its Price-to-Book (P/B) ratio in mrq is 4.26. Its current Enterprise Value per Revenue stands at 5.27 whereas that against EBITDA is -6.359.
Stock Price History:
The Beta on a monthly basis for ADPT is 1.45, which has changed by 0.5116279 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, ADPT has reached a high of $7.46, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is 8.59%, while the 200-Day Moving Average is calculated to be 45.99%.
Shares Statistics:
ADPT traded an average of 1.23M shares per day over the past three months and 1313020 shares per day over the past ten days. A total of 147.56M shares are outstanding, with a floating share count of 142.73M. Insiders hold about 3.28% of the company’s shares, while institutions hold 92.28% stake in the company. Shares short for ADPT as of 1734048000 were 9030599 with a Short Ratio of 7.50, compared to 1731628800 on 8203880. Therefore, it implies a Short% of Shares Outstanding of 9030599 and a Short% of Float of 7.8600004000000006.
